Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What we don't know about osteoporosis.

Literature DB >> 26902997

What we don't know about osteoporosis.

E M Lewiecki¹, N Binkley².

Abstract

Entities: Disease

Mesh：

Year: 2016 PMID： 26902997 DOI： 10.1007/s40618-016-0442-8

Source DB: PubMed Journal: J Endocrinol Invest ISSN： 0391-4097 Impact factor: 4.256

× No keyword cloud information.

11 in total

1. Bone density testing: science, the media, and patient care.

Authors: Micol S Rothman; Paul D Miller; E Michael Lewiecki; John P Bilezikian
Journal: Curr Osteoporos Rep Date: 2014-06 Impact factor: 5.096

Review 2. Effects of vitamin D supplements on bone density.

Authors: Ian R Reid
Journal: J Endocrinol Invest Date: 2014-07-20 Impact factor: 4.256

Review 3. Toward a physiological referent for the vitamin D requirement.

Authors: R P Heaney
Journal: J Endocrinol Invest Date: 2014-10-12 Impact factor: 4.256

Review 4. Parathyroid hormone: past and present.

Authors: John T Potts
Journal: J Endocrinol Date: 2005-12 Impact factor: 4.286

Review 5. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors: Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal: J Bone Miner Res Date: 2013-10-01 Impact factor: 6.741

Review 6. Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw.

Authors: Sanford Baim; Paul D Miller
Journal: J Bone Miner Res Date: 2009-04 Impact factor: 6.741

Review 7. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.

Authors: Aliya A Khan; Archie Morrison; David A Hanley; Dieter Felsenberg; Laurie K McCauley; Felice O'Ryan; Ian R Reid; Salvatore L Ruggiero; Akira Taguchi; Sotirios Tetradis; Nelson B Watts; Maria Luisa Brandi; Edmund Peters; Teresa Guise; Richard Eastell; Angela M Cheung; Suzanne N Morin; Basel Masri; Cyrus Cooper; Sarah L Morgan; Barbara Obermayer-Pietsch; Bente L Langdahl; Rana Al Dabagh; K Shawn Davison; David L Kendler; George K Sándor; Robert G Josse; Mohit Bhandari; Mohamed El Rabbany; Dominique D Pierroz; Riad Sulimani; Deborah P Saunders; Jacques P Brown; Juliet Compston
Journal: J Bone Miner Res Date: 2015-01 Impact factor: 6.741

8. Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors: F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal: Osteoporos Int Date: 2014-08-15 Impact factor: 4.507

9. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.

Authors: J Compston; C Bowring; A Cooper; C Cooper; C Davies; R Francis; J A Kanis; D Marsh; E V McCloskey; D M Reid; P Selby
Journal: Maturitas Date: 2013-06-27 Impact factor: 4.342

10. Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011.

Authors: Daniel H Solomon; Stephen S Johnston; Natalie N Boytsov; Donna McMorrow; Joseph M Lane; Kelly D Krohn
Journal: J Bone Miner Res Date: 2014-09 Impact factor: 6.741

8 in total

1. The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study.

Authors: C Cipriani; J Pepe; F Bertoldo; G Bianchi; F P Cantatore; A Corrado; M Di Stefano; B Frediani; D Gatti; A Giustina; T Porcelli; G Isaia; M Rossini; L Nieddu; S Minisola; G Girasole; M Pedrazzoni
Journal: J Endocrinol Invest Date: 2017-09-27 Impact factor: 4.256

2. Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy.

Authors: S Migliaccio; D Francomano; E Romagnoli; C Marocco; R Fornari; G Resmini; A Buffa; G Di Pietro; S Corvaglia; F Gimigliano; A Moretti; A de Sire; N Malavolta; A Lenzi; E A Greco; G Iolascon
Journal: J Endocrinol Invest Date: 2017-06-06 Impact factor: 4.256

3. Patients' reasons for adhering to long-term alendronate therapy.

Authors: J Pepe; C Cipriani; V Cecchetti; C Ferrara; G Della Grotta; V Danese; L Colangelo; S Minisola
Journal: Osteoporos Int Date: 2019-05-14 Impact factor: 4.507

4. The effect of parathyroid hormone (1-84) treatment on serum bone morphogenetic protein 4 and vascular endothelial growth factor in postmenopausal women with established osteoporosis.

Authors: J Pepe; C Cipriani; F P Cantatore; A Fabbri; E Pola; V Vinicola; O Raimo; F Biamonte; R Pascone; C Ferrara; S Minisola
Journal: J Endocrinol Invest Date: 2017-02-25 Impact factor: 4.256

Review 5. Osteoporosis: Treat-to-Target.

Authors: E Michael Lewiecki
Journal: Curr Osteoporos Rep Date: 2017-04 Impact factor: 5.096